#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Warm autoimmune haemolytic anaemia Neurodevelopmental disorder Astrocytoma malignant Medullary thyroid cancer Fusarium infection C3 glomerulopathy Diffuse large B-cell lymphoma refractory Synovial sarcoma Hepatitis D Juvenile idiopathic arthritis Pleomorphic liposarcoma Short stature Neurodermatitis Small intestine adenocarcinoma Breast angiosarcoma More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Diagnostics Pituitary-dependent Cushing’s syndrome – Trials in Disease Rhabdomyosarcoma – Basic Information Isodicentric chromosome 15 syndrome – Diagnostics Basal cell naevus syndrome – Basic Information Mucopolysaccharidosis – Trials in Disease Shprintzen-Goldberg syndrome – Diagnostics Hairy cell leukaemia recurrent Mucopolysaccharidosis – Life with Disease Burkitt’s lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tralokinumab Hdp-101 Sym024 Mr0005 Ranibizumab Teicoplanin Encorafenib Ziltivekimab Zanamivir L-Ascorbic Acid Deucrictibant Miransertib Prednisolone Sodium Phosphate GSKVX000000034792 Nicotine Int-787 Azd4831 Candesartan Lecanemab Procarbazine More therapies…

    Learn about Your Condition

    Breast angiosarcoma metastatic Eye inflammation Mucopolysaccharidosis III Post-traumatic stress disorder Meningioma Tympanic membrane perforation Supraventricular tachycardia Hyperhidrosis Metastases to liver Colon cancer stage III Gastrointestinal carcinoma Radiation skin injury Peritonitis Plasma cell myeloma recurrent Liver disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the effectiveness and safety of iadademstat in adults with essential thrombocythemia who do not respond well to or cannot tolerate hydroxyurea

    Recruiting

    2 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    Investigated Drugs:
    • IADADEMSTAT
    Spain

  • A study of donidalorsen for children with hereditary angioedema

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Donidalorsen
    Italy Poland Spain

  • A study comparing the effectiveness of a simeticone drug combination and a sodium picosulfate drug combination for bowel preparation in patients undergoing colorectal cancer screening.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Citric Acid
    • Magnesium Oxide, Light
    • Sodium Citrate
    Spain

  • A study to evaluate the safety and efficacy of ivosidenib, decitabine, and cedazuridine in adults with newly diagnosed acute myeloid leukemia who are older than 60 or cannot receive intensive chemotherapy.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    • Ivosidenib
    Spain

  • A study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease

    Recruiting

    3 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    France The Netherlands Poland Slovakia

  • Obinutuzumab treatment for adults with frequently relapsing idiopathic nephrotic syndrome who are dependent on rituximab

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Iohexol
    • Obinutuzumab
    Italy
Previous Page
1 … 52 53 54 55 56 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!